KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Guardant Health (GH) EBITDA Margin: 2017-2025

Historic EBITDA Margin for Guardant Health (GH) over the last 8 years, with Sep 2025 value amounting to -37.33%.

  • Guardant Health's EBITDA Margin rose 2395.00% to -37.33% in Q3 2025 from the same period last year, while for Sep 2025 it was -49.02%, marking a year-over-year increase of 2540.00%. This contributed to the annual value of -60.02% for FY2024, which is 4011.00% up from last year.
  • As of Q3 2025, Guardant Health's EBITDA Margin stood at -37.33%, which was up 18.59% from -45.85% recorded in Q2 2025.
  • Guardant Health's EBITDA Margin's 5-year high stood at -37.33% during Q3 2025, with a 5-year trough of -137.12% in Q1 2021.
  • Over the past 3 years, Guardant Health's median EBITDA Margin value was -61.28% (recorded in 2024), while the average stood at -70.50%.
  • Per our database at Business Quant, Guardant Health's EBITDA Margin plummeted by 8,540bps in 2021 and then skyrocketed by 6,497bps in 2024.
  • Quarterly analysis of 5 years shows Guardant Health's EBITDA Margin stood at -90.84% in 2021, then crashed by 2,431bps to -115.15% in 2022, then plummeted by 1,223bps to -127.38% in 2023, then spiked by 6,497bps to -62.42% in 2024, then surged by 2,395bps to -37.33% in 2025.
  • Its EBITDA Margin stands at -37.33% for Q3 2025, versus -45.85% for Q2 2025 and -54.57% for Q1 2025.